LETTER
Synthetic Routes towards Cryptophycin Unit A Diastereomers
277
L.; Moore, R. E.; Mooberry, S. L.; Corbett, T. H.; Valeriote,
(8) (a) Cram, D. J.; Elhafez, F. A. A. J. Am. Chem. Soc. 1952,
74, 5828. (b) Cram, D. J.; Wilson, D. R. J. Am. Chem. Soc.
1963, 85, 1245. (c) Chérest, M.; Felkin, H. Tetrahedron
Lett. 1968, 2205. (d) Anh, N. T. Top. Curr. Chem. 1980, 88,
145. (e) Anh, N. T.; Eisenstein, O. Nouv. J. Chim. 1977, 1,
61. (f) Anh, N. T.; Eisenstein, O. Tetrahedron Lett. 1976, 3,
155. (g) For a review, see: Mengel, A.; Reiser, O. Chem.
Rev. 1999, 99, 1191.
F. A. J. Am. Chem. Soc. 1995, 117, 12030. (d) Kobayashi,
M.; Kurosu, M.; Ohyabu, N.; Wang, W.; Kitagawa, I. Chem.
Pharm. Bull. 1994, 42, 2196. (e) Kobayashi, M.; Aoki, S.;
Ohyabu, N.; Wang, W.; Kitagawa, I. Tetrahedron Lett.
1994, 35, 7969. For reviews, see: (f) Eißler, S.; Stončius,
A.; Nahrwold, M.; Sewald, N. Synthesis 2006, 3747.
(g) Eggen, M.; Georg, G. I. Med. Res. Rev. 2002, 22, 85.
(h) Tius, M. A. Tetrahedron 2002, 58, 4343.
(9) Leonard, J.; Mohialdin, S.; Reed, D.; Ryan, G.; Swain, P. A.
(2) Al-awar, R. S.; Corbett, T. H.; Ray, J. E.; Polin, L.; Kennedy,
J. H.; Wagner, M. M.; Williams, D. C. Mol. Cancer Ther.
2004, 9, 1061.
Tetrahedron 1995, 51, 12843.
(10) Oppolzer, W. Tetrahedron 1987, 43, 1969.
(11) Hanessian, S.; Wang, W.; Gai, Y.; Olivier, E. J. Am. Chem.
Soc. 1997, 119, 10034.
(12) Morizawa, Y.; Yasuda, A.; Uchida, K. Tetrahedron Lett.
1986, 27, 1833.
(3) (a) Gardinier, K. M.; Leahy, J. W. J. Org. Chem. 1997, 62,
7098. (b) Liang, J.; Moher, E. D.; Moore, R. E.; Hoard, D.
W. J. Org. Chem. 2000, 65, 3143. (c) Pousset, C.; Haddad,
M.; Larchevêque, M. Tetrahedron 2001, 57, 7163. (d) Li,
L.-H.; Tius, M. A. Org. Lett. 2002, 4, 1637. (e) Mast, C. A.;
Eißler, S.; Stončius, A.; Stammler, H.-G.; Neumann, B.;
Sewald, N. Chem. Eur. J. 2005, 11, 4667. (f) Eißler, S.;
Nahrwold, M.; Neumann, B.; Stammler, H.-G.; Sewald, N.
Org. Lett. 2007, 9, 817.
(13) Synthesis of 7b: NaHMDS (2 M, 0.68 mmol, 0.34 mL) in
THF (2.14 mL) was cooled to –78 °C, then a solution of (R)-
ethyl 3-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-
yl]butanoate (4b, 0.68 mmol, 0.200 g) in anhyd THF
(1.6 mL) was added over 15 min and the mixture was stirred
at –78 °C over 75 min. Then, racemic 3-phenyl-2-(phenyl-
sulfonyl)-1,2-oxaziridine (0.95 mmol, 0.248 g,) in anhyd
THF (1.6 mL) was added over 15 min and the mixture stirred
at –78 °C until the reaction was complete (approx. 1 h).
Then, sat. NH4Cl solution (1.5 mL) was added over 15 min
at –78 °C and the mixture allowed to reach r.t. Afterwards,
Et2O (50 mL) and H2O (10 mL) were added, the layers
separated and the aqueous layer extracted three times with
Et2O (50 mL). The combined organic layers were washed
twice with H2O (25 mL) and sat. NaCl solution (25 mL),
dried over Na2SO4, and the solvent was evaporated under
vacuum. The residue was purified twice by chromatography
(silica gel 60, hexane–EtOAc, 4:1) to obtain reasonably pure
(2R,3R)-ethyl 3-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-di-
oxolan-4-yl]-2-hydroxybutanoate (7b, 0.56 mmol, 0.173 g,
82% yield, 77% de). Crystallisation from n-hexane gives a
diastereomerically enriched material (0.104 g, 0.34 mmol,
50%, 88% de); [a]D22 –4.44 (c 1.1, MeOH). 1H NMR (500
MHz, CDCl3): d = 7.25–7.45 (m, 5 H), 4.73 (d, J = 8.1 Hz, 1
H), 4.61 (dd, J = 5.0, 2.2 Hz, 1 H), 4.27 (m, 2 H), 4.02 (dd,
J = 8.4, 8.4 Hz, 1 H), 2.94 (d, J = 5.0 Hz, 1 H), 2.24 (qdd,
J = 8.7, 6.9, 1.9 Hz, 1 H), 1.56 (s, 3 H), 1.51 (s, 3 H), 1.31 (t,
J = 7.1 Hz, 3 H), 0.59 (d, J = 7.1 Hz, 3 H). 13C NMR (126
MHz, CDCl3): d = 174,5, 138.3, 128.6, 128.5, 127.9, 109.0,
83.5, 83.2, 71.2, 61.7, 40.2, 27.4, 27.3, 14.3, 10.2. IR (neat):
3437, 3065, 3029, 2983, 2933, 2902, 1729, 1496, 1456,
1383, 1306, 1248, 1225, 1173, 1156, 1132, 1096, 1053,
1034, 924, 880, 814, 754, 697. ESI-MS: m/z calcd for
C17H24O5Na+: 331.15 [M + Na]+; found: 331.0; m/z calcd for
C34H48O10Na+ 639.31 [2 M + Na]+; found: 638.7.
(4) Stončius, A.; Mast, C. A.; Sewald, N. Tetrahedron:
Asymmetry 2000, 11, 3849.
(5) Synthesis of 4b
Copper(I) iodide (25.34 mmol, 4.826 g) was dried for 2 h in
high vacuum at 100 °C, deoxygenated three times with
argon and suspended in anhyd toluene (52 mL). The mixture
was cooled to –78 °C, then MeLi (1.4 M) in Et2O (18.1 mL)
was added over 20 min. While the reaction mixture was
warmed to –40 °C for 15 min, the suspension turned bright
yellow. The mixture was cooled to –78 °C again and
BF3·OEt2 (25.2 mmol, 3.58 g, 3.10 mL) was added dropwise
and the mixture was stirred for 15 min at –78 °C. Then a
solution of (E)-ethyl 3-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-
dioxolan-4-yl]acrylate (3, 7.24 mmol, 2.000 g) in anhyd
toluene (5 mL) was added dropwise and after the addition
was complete, the reaction mixture was stirred for 16 h at
–78 °C. A 9:1 mixture of aq NH4Cl solution and 25% aq
NH4OH solution (6 mL) was added over 30 min at –78 °C,
and the cooling bath was removed. Then, H2O (50 mL) and
hexane (200 mL) were added to the reaction, and the mixture
was filtered through a pad of Celite®. The layers of the
filtrate were separated, the aqueous phase was extracted
three times with hexane (50 mL) and the combined organic
layers were washed with sat. NaCl solution (30 mL) and
dried over Na2SO4. The solvent was removed under vacuum
(50 °C). The crude product was purified by flash
chromatography (hexane–EtOAc, 12:1) yielding (R)-ethyl
3-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-
yl]butanoate (4b, 1.106 g, 52%, 92% de) as a slightly yellow,
highly viscous oil. For the analytical data see ref. 4.
(6) Yamamoto, Y.; Maruyama, K. J. Am. Chem. Soc. 1978, 100,
3240.
(14) CCDC 668175 (7b) and 668176 (9a) contain the
supplementary crystallographic data for this paper. These
data can be obtained free of charge from The Cambridge
data_request/cif.
(7) (a) Yamamoto, Y.; Chounan, Y.; Nishii, S.; Ibuka, T.;
Kitahara, H. J. Am. Chem. Soc. 1992, 114, 7652.
(b) Dorigo, A. E.; Morokuma, K. J. Am. Chem. Soc. 1989,
111, 6524.
Synlett 2008, No. 2, 273–277 © Thieme Stuttgart · New York